NCT02151370View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Ovarian Cancer

Trial Locations (1)

01101

San Salvador

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02151370 - An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter